• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY; PERIPHERALLY INSERTED CENTRAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY; PERIPHERALLY INSERTED CENTRAL CATHETER Back to Search Results
Model Number 45891
Medical Device Problem Code Detachment of Device or Device Component (2907)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/07/2021
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
It was reported that the device is not available to be returned to the manufacturer for evaluation.The results of the investigation will be sent via a follow up medwatch.Reference (b)(4).
 
Event or Problem Description
A distributor reported an issue with a bio-stable 4f sl 55cm mst-70 kit valved with nitinol guidewire.The following was reported: on (b)(6) 2021 the picc was successfully placed.Later that same day, the patient received cxr to confirm the tip location.It was noted the picc tip had crossed to the left subclavian by approximately 7cm.The picc was pulled back by 7.5cm and it was determined it was okay to continue using.On (b)(6) 2021, during ivc (r) hand, the picc site was dressed with crepe bandage.It was noted strike through bleeding.The medical personnel covered the site and was not concerned.The picc was able to be accessed still.Ivabx was administered as charted.It was also noted the patient's left foot was showing oedema, redness.The patient stated it was not causing any pain or issues.On (b)(6) 2021, the patient reported to nurse that he was bleeding.The nurse reported: "i looked at the picc, noticed the bung had been removed and it was bleeding.I put a bung on the picc and cleaned the patient up".The nurse informed their team leader and medical team and the picc was removed later that same day (b)(6) as per the medical team's instruction.The picc was discarded following removal.The picc was not replaced with a new one as the patient refused.The patient was discharged (b)(6) 2021.There was no report of permanent patient harm or injury due to this event.The reported device is not available to be returned to the manufacturer for evaluation.
 
Additional Manufacturer Narrative
As the reported device was not returned, angiodynamics is unable to perform a device evaluation.The customer's complaint description pasv valve bleed back could not be confirmed, no sample was returned.Without receiving product for evaluation, we are unable to definitively determine a root cause for this incident.The device history records for the bioflo pasv picc packaging and picc assembly lots were reviewed for any deviations related to the reported leaked failure mode.The review confirms that the lots met all material, assembly and performance specifications with no internal non-conformance reports (ncr) written.Labeling review: the dfu that is supplied in bioflo kits item number {16600224-01} contains the following precaution: it is recommended that only luer lock accessories be used with the · bioflo¿ picc with endexo¿ and pasv¿ valve technology.Repeated over-tightening may reduce hub connector life.Do not use hemostats to secure or remove devices with luer lock hub connections.Flushing - recommended procedure: 1.Flush the catheter after every use, or at least every seven days when not in use, to maintain patency.Use a 10 ml syringe or larger.2.Flush the catheter with a minimum of 10 ml of sterile normal saline, using a "pulse" or "stop/start" technique.Warning: if using bacteriostatic saline, do not exceed 30 ml in a 24-hour period.3.Disconnect the syringe and attach a sterile end cap to each luer lock hub.Note: this is the recommended flush procedure for this catheter.If using a different procedure than listed above, the use of heparin may be necessary.Follow institutional protocol for catheter flushing.Precaution: incompatible drug delivery within the same lumen may cause precipitation.Ensure that the catheter lumen is flushed following each infusion.Precaution: if resistance is met when flushing, it is recommended that no further attempts be made.Further flushing may result in catheter rupture.Refer to institutional protocol for clearing occluded catheters.Precaution: place a cap on the hub after use to reduce the risk of contamination.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint will continue to be monitored for trends.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOFLO PICC WITH ENDEXO AND PASV VALVE TECHNOLOGY
Common Device Name
PERIPHERALLY INSERTED CENTRAL CATHETER
Manufacturer (Section D)
ANGIODYNAMICS
10 glens falls technical park
glens falls, ny 12801 NY 12801
MDR Report Key12392007
Report Number1317056-2021-00160
Device Sequence Number20105664
Product Code LJS
UDI-Device IdentifierH965458910
UDI-PublicH965458910
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K121089
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source distributor,foreign
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/31/2022
Device Model Number45891
Device Catalogue Number45891
Device Lot Number5658533
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/07/2021
Supplement Date Received by Manufacturer10/29/2021
Initial Report FDA Received Date08/31/2021
Supplement Report FDA Received Date11/02/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age71 YR
-
-